Teresa Quattrin MD
Teresa Quattrin
MD
UB Distinguished Professor; Senior Associate Dean for Research Integration
Jacobs School of Medicine & Biomedical Sciences
Specialty/Research Focus
Pediatric Diabetes; Pediatric Endocrinology; Pediatrics
Contact Information
Patient Care
Patient Care
This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.
View this physician on UBMDEducation and Training:
- Fellowship, Pediatric Endocrinology, University at Buffalo (1990)
- Residency, Pediatrics, University at Buffalo (1989)
- Fellowship, Pediatric Endocrinology, University at Buffalo (1988)
- Fellowship, Pediatric Endocrinology, University at Buffalo (1986)
- Residency, Pediatrics, University of Naples School of Medicine (1985)
- Internship, Pediatrics, University of Naples School of Medicine (1983)
- MD, Medicine, University of Naples School of Medicine, Magna Cum Laude (1982)
Employment:
- Associate Dean for Reasearch Integration, Jacobs School of Medicine and Biomedical Sciences (2022-present)
- Senior Associate Dean for Research Integration, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (2018-present)
- Distinguished Professor, University at Buffalo (2011-present)
- Professor, Pediatrics, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (2007-present)
- Attending Physician, Endocrinology/Diabetes, Oishei Children's Hospital (1990-present)
- A. Conger Goodyear Professor and Chair, Pediatrics, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (2010–2017)
- Pediatrician-in-Chief, Oishei Children's Hospital (2010–2017)
- President, UBMD Pediatrics (2010–2017)
- Pediatric Chief-of-Service, Kaleida Health (2007–2017)
- Division Chief, Endocrinology/Diabetes, UBMD Pediatrics (2002–2017)
- Interim Chair, Pediatrics, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (2007–2010)
- Interim Pediatrician-in-Chief, Women and Children's Hospital of Buffalo (2007–2010)
- Fellowship Program Director, Endocrinology/Diabetes, University at Buffalo (2002–2009)
- Associate Professor, Pediatrics, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (1996–2007)
- Director, Diabetes Center, Women and Children's Hospital of Buffalo (1990–2001)
- Assistant Professor, Pediatrics, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (1990–1996)
- Attending Physician, Emergency Medicine, Women and Children‘s Hospital of Buffalo (1989–1990)
- Research Assistant Professor, Pediatrics, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (1987–1988)
Awards and Honors:
- Top 20 Clinical Research Achievement Award Finalist in the US (2020)
- Buffalo Translational Consortium Clinical Research Achievement Award Winner (2020)
- Buffalo Business First: Women of Influence Award (2016)
- Seneca Diabetes Foundation: Chairman Award (2016)
- American Men and Women of Science (2015)
- Best Doctors in America (2014)
- D'Youville College: Achievement in Health Care Award (2012)
- University at Buffalo: Distinguished Professor (2011)
- A. Conger Goodyear Endowed Chair (2010)
- Seneca Diabetes Foundation: Endowed Chair at Women and Children's Hospital of Buffalo (2007)
Research Expertise:
- Growth hormone deficiency
- Type 1 diabetes
- Type 2 diabetes
- Weight management and obesity
Grants and Sponsored Research:
- March 2020–January 2025
Buffalo Clinical and Translational Research Center
NIHNCATS
Role: Co-Investigator - February 2021–February 2024
Addressing the Health Digital Divide in Elders
Western New York Digital Equity Coalition Pilot grants
Role: Principal Investigator - June 2016–May 2021
The Effectiveness of Family-based Weight Loss Treatment Implemented in Primary Care – CCC – Lead Application
National Institutes of Health
Role: Co-Investigator
$5,615,697 - August 2015–July 2020
Delay Discounting as a Target for Self-Regulation in Prediabetes
National Institute of Diabetes and Digestive and Kidney Diseases
Role: Co-Investigator
$2,417,153 - January 2015–December 2019
Using Prospection to Improve Obesity Treatment
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Role: Co-Investigator
$2,191,299 - January 2017–January 2019
Phase 2 SIMPONI to Arrest B-cell Loss in Type 1 Diabetes
Janssen Research and Development, LLC
Role: Principal Investigator
$66,371 - September 2008–June 2018
Type 1 Diabetes TrialNet
National Institutes of Health
Role: Principal Investigator
$421,720 - January 2015–January 2017
Versartis 14VR4 - Comparison of VRS-317, a Long-Acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-Year, Open-Label, Multi-Center, Non-Inferiority Trial in Pre-Pubertal Children with Growth Hormone
Versartis, Inc.
Role: Principal Investigator
$12,851 - January 2014–January 2017
A Long-Acting Human Growth Hormone (VRS-317) in Pre-Pubertal Children with Growth Hormone Deficiency: A Randomized, Open-Label, Multi-Center, Phase 1b
Versartis, Inc.
Role: Principal Investigator
$17,537 - January 2011–January 2016
The Western New York Project for Pediatric Obesity Prevention (WNYOPP)
New York State Department of Health
Role: Principal Investigator
$622,500 - January 2012–January 2015
A Long-Acting Human Growth Hormone (VRS-317) in Pre-Pubertal Children with Growth Hormone Deficiency: A Randomized, Open-Label, Multi-Center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy after Subcutaneous Ad
Versartis, Inc.
Role: Principal Investigator
$49,480 - December 2012–November 2014
Anti-Diabetic Effects of Liraglutide in Adolescents and Young Subjects with Type 1 Diabetes
American Diabetes Association
Role: Co-Investigator
$600,000 - January 2011–January 2014
Overweight Prevention in the Western New York Community
Women and Children‘s Hospital of Buffalo Foundation
Role: Principal Investigator
$468,000 - January 2008–January 2013
Treating Overweight Youth: A Family-Based Approach in Primary Care
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Role: Principal Investigator
$2,691,955 - January 2011–January 2012
Buffalo Healthy Tots Follow-Up Program
Wildermuth Foundation
Role: Principal Investigator
$25,000 - January 2006–January 2012
New York State Center of Excellence for Type 2 Diabetes
New York State Department of Health
Role: Principal Investigator
$550,000 - January 2002–January 2008
Randomized, Placebo Based, Double-Blind Study Evaluating the Feasibility and Safety of ETANERCEPT Subcutaneous Administration in Pediatric Subjects with Type 1 Diabetes Mellitus to Prolong the Partial Remission Period
Amgen
Role: Principal Investigator
$106,648 - October 2021
Effects of complex mixtures on oxidative stress and cognition in children
Lumos Pharma
Role: Principal Investigator - March 2020
Accomplish: A Phase 2, multicenter, double-blind, randomized, placebo-controlled, dose escalation trial evaluating safety, efficacy, and pharmacokinetics of subcutaneous doses of TransCon CNP administered weekly for 12 months in pre-pubertal children with achondroplasia
ASCENDIS
Role: Principal Investigator
$63,000 - April 2019
A Personalized Medicine Approach to Improve Bariatric Surgery Outcomes Utilizing Psychosocial and Genetic Risk Assessments
University at Buffalo: Blue Sky Fund
Role: Principal Investigator
$25,000 - April 2017
Role of Contingency Management in the Treatment of Youth and Their Parents in a Pediatric Tertiary Care Weight Management Program
University at Buffalo Clinical and Translational Science Institute
Role: Co-Investigator
$42,000 - May 2006
Type 1 Diabetes TrialNet
National Institute of Diabetes and Digestive and Kidney Diseases
Role: Principal Investigator
$311,019
Journal Articles:
- Powell A, Hanna C, Sajjad M, Yao R, Blum K, Gold MS, Quattrin T, Thanos PK. (2024) Exercise Influences the Brain's Metabolic Response to Chronic Cocaine Exposure in Male Rats. Journal of personalized medicine (May), 14(5). doi:10.3390/jpm14050500
- Savarirayan R, Hoernschemeyer DG, Ljungberg M, Zarate YA, Bacino CA, Bober MB, Legare JM, Högler W, Quattrin T, Abuzzahab MJ, Hofman PL, White KK, Ma NS, Schnabel D, Sousa SB, Mao M, Smith A, Chakraborty M, Giwa A, Winding B, Volck B, Shu AD, McDonnell C. (2023) Once-weekly TransCon CNP (navepegritide) in children with achondroplasia (ACcomplisH): a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-escalation trial. EClinicalMedicine (Nov), 65: 102258. doi:10.1016/j.eclinm.2023.102258
- Button AM, Paluch RA, Schechtman KB, Wilfley DE, Geller N, Quattrin T, Cook SR, Eneli IU, Epstein LH. (2023) Parents, but not their children, demonstrate greater delay discounting with resource scarcity. BMC public health (Oct), 23(1): 1983. doi:10.1186/s12889-023-16832-z
- Ramel M, Wilfley DE, Tabak R, Lew D, Moursi NA, Kilanowski C, Cook SR, Eneli IU, Quattrin T, Schechtman KB, Epstein LH. (2023) Relationships examined: Parent and child readiness to change and sociodemographic characteristics in family based weight loss treatment. Pediatric obesity (Sep), 18(9): e13062.
- Thanos PK, Hanna C, Mihalkovic A, Hoffman A, Posner A, Butsch J, Blum K, Georger L, Mastrandrea LD, Quattrin T. (2023) Genetic Correlates as a Predictor of Bariatric Surgery Outcomes after 1 Year. Biomedicines (Sep), 11(10). doi:10.3390/biomedicines11102644
- Thanos PK, Hanna C, Mihalkovic A, Hoffman AB, Posner AR, Busch J, Smith C, Badgaiyan RD, Blum K, Baron D, Mastrandrea LD, Quattrin T. (2023) The First Exploratory Personalized Medicine Approach to Improve Bariatric Surgery Outcomes Utilizing Psychosocial and Genetic Risk Assessments: Encouraging Clinical Research. Journal of personalized medicine (Jul), 13(7). doi:10.3390/jpm13071164
- Epstein LH, Wilfley DE, Kilanowski C, Quattrin T, Cook SR, Eneli IU, Geller N, Lew D, Wallendorf M, Dore P, Paluch RA, Schechtman KB. (2023) Family-Based Behavioral Treatment for Childhood Obesity Implemented in Pediatric Primary Care: A Randomized Clinical Trial. JAMA (Jun), 329(22): 1947-1956. doi:10.1001/jama.2023.8061
- Quattrin T, Mastrandrea LD, Walker LSK. (2023) Type 1 diabetes. Lancet (London, England) (Jun), 401(10394): 2149-2162.
- Hamilton J, Nguyen C, McAvoy M, Roeder N, Richardson B, Quattrin T, Hajnal A, Thanos PK. (2023) Calorie restriction, but not Roux-en-Y gastric bypass surgery, increases [3 H] PK11195 binding in a rat model of obesity. Synapse (New York, N.Y.) (Mar), 77(2): e22258.
- Majumdar I, Talal AH, Harmon CM, Tabaczynsk E, Cercone K, Wrotniak BH, Mastrandrea LD, Quattrin T. (2023) Role of Dual-Contingency Management in Family-Based Obesity Therapy and the Effects of Weight Loss on Liver Transient Elastography Parameters in Youth: A Pilot Study. Cureus (Mar), 15(3): e36629. doi:10.7759/cureus.36629
- Rigby MR, Hayes B, Li Y, Vercruysse F, Hedrick JA, Quattrin T. (2023) Two-Year Follow-up From the T1GER Study: Continued Off-Therapy Metabolic Improvements in Children and Young Adults With New-Onset T1D Treated With Golimumab and Characterization of Responders. Diabetes care (Mar), 46(3): 561-569. doi:10.2337/dc22-0908
- Mastrandrea LD, Quattrin T. (2022) Preventing Type 1 Diabetes Development and Preserving Beta-Cell Function. Curr Opin Endocrinol Diabetes Obes. 2022 Aug 1;29(4):386-391. (Jul) doi:doi:10.1097/MED.0000000000000746. Epub 2022 Jul 2.
- Neuman J, Roeder N, Richardson B, Quattrin T, Hamilton J, Thanos PK. (2022) High Fat Diet Increases [3 H] Flunitrazepam Binding in the Mouse Brain that is Dependent on the Expression of the Dopamine D2 Gene. Neurochemical Research. (Jun) doi:http://doi.org/10.1007/s11064-022-03644-7
- Hamilton J, Nguyen C, McAvoy M, Reader N, Richardson B, Quattrin T, Hajnal A, Thanos PK,. (2022) Calorie restriction, but not Roux-en Y gastric bypass surgery, Increases [3H] PK 11195 binding in a rat model of obesity. Synapse Online 2022. (Jan) doi:http://doi.org/10.1002/syn.22258
- Quattrin T, Mastrandrea LD, Walker L. (2022) Type 1 Diabetes: Current Landscape. Invited Seminar. The Lancet- In press. (Jan)
- Rigby MR, Hayes B, Li Y, Vercruysse V, Hedrick JA, Quattrin T. (2022) Two-Year Follow-up from the T1GER Study: Continued off- Therapy Metabloic Improvements in Children and Young Adults with New-Onset T1D Treated with Golimumab and Characterization of Responders. Diabetes Care 2023: 46: 1-9. (Jan) doi:http://doi.org/ 10.2337/dc22-0908
- Epstein LH, Schechtman KB, Kilanowski C, Moursi NA, Quattrin T, Cook SR, Eneli IU, Pratt C, Geller N, Campo R, Lew D, Wifley DE. (2021) Implementing family-based behavioral treatment in the pediatric primary care setting: Design of the PLAN study. Contemporary Clinical Trials (Oct) doi:https://doi.org/10.1016/j.cct.2021.106497
- Shelat T, Mastrandrea LD, Majumdar I, and Quattrin T. (2021) Perception of Diabetes Self-Efficacy and Glycemic Control in Youth with Type 1 Diabetes. Diabetes Spectrum (Feb) doi:https://doi.org/10.2337/ds20-0035
- Stein JS, Craft WH, Paluch RA, Gatchalian KM, Greenawald MH, Quattrin T, Mastrandrea LD, Epstein LH, Bickel WK. (2021) Bleak present, bright future: II. Combined effects of episodic future thinking and scarcity on delay discounting in adults at risk for type 2 diabetes. J. Behav Med. (Jan), 2(44): 222-230. doi:10.1007/s10865-020-00178-7
- Quattrin T, Haller MJ, Steck AK, Felner EI, Li Y, Xia Y, Leu JH, Zoka R, Hedrick JA, Rigby MR, Vercruysse F. (2020) Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes. N Engl J Med (Nov), 383(21): 2007-2017.
- Stein JS, Craft WH, Paluch RA, Gatchalian KM, Greenawald MH, Quattrin T, Mastrandrea LD, Epstein LH, Bickel WK. (2020) Bleak present, bright future: II. Combined effects of episodic future thinking and scarcity on delay discounting in adults at risk for type 2 diabetes. J Behav Med (Sep).
- Bickel WK, Stein JS, Paluch RA, Mellis AM, Athamneh LN, Quattrin T, Greenawald MH, Bree KA, Gatchalian KM, Mastrandrea LD, Epstein LH. (2020) Does Episodic Future Thinking Repair Immediacy Bias at Home and in the Laboratory in Patients With Prediabetes?. Psychosom Med (Sep), 82(7): 699-707.
- Epstein LH, Paluch RA, Stein JS, Quattrin T, Mastrandrea LD, Bree KA, Sze YY, Greenawald MH, Biondolillo MJ, Bickel WK. (2020) Delay Discounting, Glycemic Regulation and Health Behaviors in Adults With Prediabetes. Behav Med (Apr).
- Epstein LH, Quattrin T. (2020) Ideas for Next-Generation Treatments of Adolescent Obesity. JAMA Pediatr (Mar), 174(6): 527-528.
- Epstein LH, Paluch RA, Stein JS, Mellis AM, Quattrin T, Mastrandrea LD, Bree KA, Greenawald MH, Bickel WK. (2019) Role of Delay Discounting in Predicting Change in HBA1c for Individuals With Prediabetes. J Behav Med (Oct), 42(5): 851-859.
- Carias E, Hamilton J, Robison LS, Delis F, Eiden R, Quattrin T, Hadjiargyrou M, Komatsu D, Thanos PK, Thanos P. (2018) Chronic oral methylphenidate treatment increases microglial activation in rats. J Neural Transm (Vienna) (Dec), 125(12): 1867-1875.
- Clapp DW, Quattrin T, Jacobs RF, Opipari VC. (2018) Hospitalist Medicine-Chairs' Perspective of Specialty Status and Training Requirements. J Pediatr (Feb), 193: 4-8.
- Quattrin T, Cao Y, Paluch RA, Roemmich JN, Ecker MA, Epstein LH. (2017) Cost-effectiveness of Family-Based Obesity Treatment. Pediatrics (Sep), 140(3).
- Quattrin T, Wilfley DE. (2017) The Promise and Opportunities for Screening and Treating Childhood Obesity: USPSTF Recommendation Statement. JAMA Pediatr (Aug), 171(8): 733-735.
- Majumdar I, Bethin KE, Quattrin T. (2015) Weight trajectory of youth with new-onset type 1 diabetes comparing standard and enhanced dietary education. Endocrine (May), 49(1): 155-162.
- Bethin KE, Rafalson L, Creighton PR, Ghanim H, Dandona P, Nagai AS, Quattrin T. (2015) Anthropometric and metabolic characteristics of overweight and normal weight preschoolers: a cross-sectional study. Obes Control Ther (Mar), 2(1): 1-6.
- Quattrin T, Roemmich JN, Paluch R, Yu J, Epstein LH, Ecker MA. (2014) Treatment outcomes of overweight children and parents in the medical home. Pediatrics (Aug), 134(2): 290-297.
- Danilovich N, Mastrandrea LD, Cataldi L, Quattrin T. (2014) Methylphenidate decreases fat and carbohydrate intake in obese teenagers. Obesity (Silver Spring) (Mar), 22(3): 781-785.
- Mogri M, Dhindsa S, Quattrin T, Ghanim H, Dandona P. (2013) Testosterone concentrations in obese post-pubertal males. Clin Endocrinol (Oxf) (Apr), 78(4): 593-599.
- Mogri M, Dhindsa S, Quattrin T, Ghanim H, Dandona P. (2013) Testosterone concentrations in young pubertal and post-pubertal obese males. Clin Endocrinol (Oxf) (Apr), 78(4): 593-599.
- Quattrin T, Roemmich JN, Paluch R, Yu J, Epstein LH, Ecker MA. (2012) Efficacy of family-based weight control program for preschool children in primary care. Pediatrics (Oct), 130(4): 660-666.
- Rafalson L, Eysaman J, Quattrin T. (2011) Screening obese students for acanthosis nigricans and other diabetes risk factors in the urban school-based health center. Clin Pediatr (Phila) (Aug), 50(8): 747-752.
- Daniel M, Mastrandrea LD, Salis R, Erbe RW, Quattrin T. (2010) Does the dopamine transporter protein allele predict growth hormone testing results or response to growth hormone therapy?. Endocrine (Apr), 37(2): 361-364.
- Quattrin T. (2009) Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study: response to Peters. Diabetes Care (Dec), 32: 12-12.
- Mastrandrea LD, Yu J, Behrens T, Buchlis JG, Albini CH, Fourtner SH, Quattrin T. (2009) Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study. Diabetes Care (Jul), 32(7): 1244-1249.
- Mastrandrea LD, Wactawski-Wende J, Donahue RP, Hovey KM, Clark A, Quattrin T. (2008) Young women with type 1 diabetes have lower bone mineral density that persists over time. Diabetes Care (Sep), 31(9): 1729-1735.
- White NH, Quattrin T, St Aubin LB, Duggan WT, England RD, Fryburg JS. (2008) Efficacy and safety of inhaled human insulin (Exubera) compared to subcutaneous insulin in children ages 6 to 11 years with type 1 diabetes mellitus: results of a 3-month, randomized, parallel trial. J Pediatr Endocrinol Metab (Jun), 21(6): 555-568.
- Cappelleri JC, Gerber RA, Quattrin T, Deutschmann R, Luo X, Arbuckle R, Abetz L. (2008) Development and validation of the WEll-being and Satisfaction of CAREgivers of Children with Diabetes Questionnaire (WE-CARE). Health Qual Life Outcomes (Jan), 6: 3-3.
- Sutu E, Crespo CJ, Shine B, Doshi A, Quattrin T. (2006) Detecting overweight children in primary care: do national data reflect the typical urban practice?. J Fam Pract (Nov), 55(11): 976-980.
- Mastrandrea LD, Quattrin T. (2006) Clinical evaluation of inhaled insulin. Adv Drug Deliv Rev (Oct), 58(9-10): 1061-1075.
- Quattrin T. (2006) Inhaled insulin: a novel and non-invasive way for insulin administration?. Curr Drug Saf (May), 1(2): 151-158.
- Quattrin T. (2005) Current knowledge and future directions in the complex field of pediatric overweight. Trends in Endocrinology and Metabolism (Dec), 16(10): 443-444.
- Fuhrman BP, Barba M, Schünemann HJ, Hurd T, Quattrin T, Cartagena R, Carruba G, Muti P. (2005) Basal growth hormone concentrations in blood and the risk for prostate cancer: a case-control study. Prostate (Jul), 64(2): 109-115.
- Quattrin T, Liu E, Shaw N, Shine B, Chiang E. (2005) Obese children who are referred to the pediatric endocrinologist: characteristics and outcome. Pediatrics (Feb), 115(2): 348-351.
- Quattrin T. (2004) Inhaled insulin: recent advances in the therapy of Type 1 and 2 diabetes. Expert Opin Pharmacother (Dec), 5(12): 2597-2604.
- Quattrin T, Bélanger A, Bohannon NJ, Schwartz SL. (2004) Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial. Diabetes Care (Nov), 27(11): 2622-2627.
- Everhart DE, Shucard JL, Quattrin T, Shucard DW. (2004) Tone probe event-related potential differences during a face recognition task in prepubertal children and Turner Syndrome girls. Psychoneuroendocrinology (Nov), 29(10): 1260-1271.
- Roemmich JN, Liu EY, Rogol AD, Epstein LH, Quattrin T. (2004) Diminished insulin resistance with weight loss in severely overweight youth. Metab Syndr Relat Disord (Sep), 2(3): 160-168.
- Liu EY, Wactawski-Wende J, Donahue RP, Dmochowski J, Hovey KM, Quattrin T. (2003) Does low bone mineral density start in post-teenage years in women with type 1 diabetes?. Diabetes Care (Aug), 26(8): 2365-2369.
- Muti PC, Quattrin T, Grant BJ, Krogh V, Micheli A, Schünemann HJ, Ram M, Freudenheim JL, Sieri S, Trevisan M, Berrino F, Schunemann HJ. (2002) Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev (Nov), 11(11): 1361-1368.
- Muti P, Gaddi P, Quattrin T. (2002) Correspondence re: Chokkalingam A. et al., Insulin-like growth factors and prostate cancer: a population-based case-control study in China. Cancer Epidemiol. Biomark. Prev., 10: 421-427, 2001. Cancer Epidemiol Biomarkers Prev (Mar), 11(3): 323-323.
- Quattrin T, Thrailkill K, Baker L, Kuntze J, Compton P, Martha P. (2001) Improvement of HbA1c without increased hypoglycemia in adolescents and young adults with type 1 diabetes mellitus treated with recombinant human insulin-like growth factor-I and insulin. rhIGF-I in IDDM Study Group. J Pediatr Endocrinol Metab (Mar), 14(3): 267-277.
- Maclaren N, Lan M, Coutant R, Schatz D, Silverstein J, Muir A, Clare-Salzer M, She JX, Malone J, Crockett S, Schwartz S, Quattrin T, DeSilva M, Vander Vegt P, Notkins A, Krischer J. (1999) Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives. J Autoimmun (Jun), 12(4): 279-287.
- Thrailkill KM, Quattrin T, Baker L, Kuntze JE, Compton PG, Martha PM. (1999) Cotherapy with recombinant human insulin-like growth factor I and insulin improves glycemic control in type 1 diabetes. RhIGF-I in IDDM Study Group. Diabetes Care (Apr), 22(4): 585-592.
- Thrailkill K, Quattrin T, Baker L, Litton J, Dwigun K, Rearson M, Poppenheimer M, Kotlovker D, Giltinan D, Gesundheit N, Martha P. (1997) Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: effects on the growth hormone/IGF/IGF-binding protein system. J Clin Endocrinol Metab (Apr), 82(4): 1181-1187.
- Quattrin T, Thrailkill K, Baker L, Litton J, Dwigun K, Rearson M, Poppenheimer M, Giltinan D, Gesundheit N, Martha P. (1997) Dual hormonal replacement with insulin and recombinant human insulin-like growth factor I in IDDM. Effects on glycemic control, IGF-I levels, and safety profile. Diabetes Care (Mar), 20(3): 374-380.
- Cantor AB, Krischer JP, Cuthbertson DD, Schatz DA, Riley WJ, Malone J, Schwartz S, Quattrin T, Maclaren NK. (1995) Age and family relationship accentuate the risk of insulin-dependent diabetes mellitus (IDDM) in relatives of patients with IDDM. J Clin Endocrinol Metab (Dec), 80(12): 3739-3743.
- Waz WR, Quattrin T, Feld LG. (1995) Hematuria in children and adolescents with insulin-dependent diabetes mellitus. J Diabetes Complications (Jul), 9(3): 194-197.
- Quattrin T, Waz WR, Duffy LC, Sheldon MW, Campos SP, Albini CH, Feld LG. (1995) Microalbuminuria in an adolescent cohort with insulin-dependent diabetes mellitus. Clin Pediatr (Phila) (Jan), 34(1): 12-17.
- Quattrin T, Albini CH, Sportsman C, Shine BJ, Macgillivray MH. (1993) Urinary insulin-like growth factor-II excretion in healthy infants and children with normal and abnormal growth. Pediatr Res (Oct), 34(4): 435-438.
- Krischer JP, Schatz D, Riley WJ, Spillar RP, Silverstein JH, Schwartz S, Malone J, Shah S, Vadheim CM, Rotter JI, Quattrin T, Maclaren N. (1993) Insulin and islet cell autoantibodies as time-dependent covariates in the development of insulin-dependent diabetes: a prospective study in relatives. J Clin Endocrinol Metab (Sep), 77(3): 743-749.
- Waz WR, Quattrin T, Feld LG. (1993) Serum creatinine, height, and weight do not predict glomerular filtration rate in children with IDDM. Diabetes Care (Aug), 16(8): 1067-1070.
- Albini CH, Quattrin T, Mills B, Sherman B, Johanson A, Macgillivray MH. (1992) Urinary growth hormone and insulin-like growth factor I. Effects of growth-hormone injection schedule. Clin Pediatr (Phila) (Sep), 31(9): 542-545.
- Quattrin T, Albini CH, Reiter EO, Mills BJ, Macgillivray MH. (1992) Urinary excretion of IGF-I and growth hormone in children with IDDM. Diabetes Care (Apr), 15(4): 490-494.
- Albini CH, Sotos J, Sherman B, Johanson A, Celniker A, Hopwood N, Quattrin T, Mills BJ, Macgillivray MH. (1991) Diagnostic significance of urinary growth hormone measurements in children with growth failure: correlation between serum and urine growth hormone. Pediatr Res (Jun), 29(6): 619-622.
- Tenore A, Franzese A, Quattrin T, Sandomenico ML, Aloi G, Gallo P, Mariano A, Di Maio S. (1991) Prognostic signs in the evolution of premature thelarche by discriminant analysis. J Endocrinol Invest (May), 14(5): 375-381.
- Quattrin T, Aronica S, Mazur T. (1990) Management of male pseudohermaphroditism: a case report spanning twenty-one years. J Pediatr Psychol (Dec), 15(6): 699-709.
- Quattrin T, Albini CH, Mills BJ, MacGillivray MH. (1990) Comparison of urinary growth hormone and IGF-I excretion in small- and appropriate-for-gestational-age infants and healthy children. Pediatr Res (Sep), 28(3): 209-212.
- Quattrin T, Albini CH, Cara JF, Vandlen RL, Mills BJ, Macgillivray MH. (1988) Quantitation of urinary somatomedin-C and growth hormone in preterm and fullterm infants and normal children. J Clin Endocrinol Metab (Apr), 66(4): 792-797.
- Albini CH, Quattrin T, Vandlen RL, MacGillivray MH. (1988) Quantitation of urinary growth hormone in children with normal and abnormal growth. Pediatr Res (Jan), 23(1): 89-92.
- Quattrin T, McPherson E, MacGillivray MH, Afshani E. (1988) Macrosomia, unusual facies, and early developmental delay. Dysmorphol Clin Genet (Jan), 2: 16-20.
- Quattrin T, Albini CH, Vandlen RL, MacGillivray MH. (1987) Quantitation of urinary somatomedin-C in children with normal and abnormal growth. J Clin Endocrinol Metab (Dec), 65(6): 1168-1171.
- Quattrin T, McPherson E, Putnam TI. (1987) Vertical transmission of the neurofibromatosis/Noonan syndrome. Am J Med Genet (Mar), 26(3): 645-649.
- Quattrin T, Salerno MC, Nunziata L, Sandomenico ML, Tenore A. (1986) Inappropriate use of topical corticosteroids in infancy. Italian Journal of Pediatrics (Jan), 12: 61-64.
- Sandomenico ML, Nunziata L, Quattrin T, Tenore A. (1984) Evaluation in growth pattern. Il Pediatra (Oct), 31.
- Tenore A, Sandomenico ML, Quattrin T, Di Maio S. (1984) Obesity, the malnutrition of civilized countries. Il Pediatra (Apr), 13.
Books and Book Chapters:
- Thanos P, Lamoshi A, Nubelo A, Hamilton J, Chernoguz A, Hoffman AB, Quattrin T, Harmon C. (2021) Clinical and Preclinical Bariatric Surgery Approaches to Studying Obesity. In: Animal Models of Eating Disorders, Neuromethods,. © Springer Science+Business Media, LLC, part of Springer Nature
- Majumdar I, Quattrin T. (2015) In: "Obesity". American Academy of Pediatrics, 415-428.
Abstracts:
- Savarirayan R, Hoernschemeyer DG, Ljungberg M, Bacino CA, Legare JM, Quattrin T, Zarate YA, Abuzzahab J, Hofman PL, Hogler W, Schnabel D, Carroll R, White KK, Sousa SB, Mao M, Smith A, Kjelgaard-Hansen M, Shu AD, McDonnell C. (2024) TransCon CNP (Navepegritide) Improves Physical Functioning and Well-Being in Children with Achondroplasia (ACH) in the ACcomplisH Trial. International Conference on Children's Bone Health, 6/22-25, 2024. Salzburg, (Jun) Poster
- Wiefley D, Rudolph S, Kilanowski C, Quattrin T, Cook SR, Eneli IU, Geller N, Lew D, Wallendorf M, Dore P, Schechtman KB. (2023) "An RCT in Primary Care: Family-Based Behavioral Treatment versus Usual Care for Childhood Obesity". Obesity week October 14-17, 2023. (Oct) Poster
- Shaw N, Liu EY, Lu S, Shine B, Quattrin T. (2003) Obese Children Referred to the Pediatric Endocrinologist: Characteristics and Outcome. Pediatr Res, (Jan) 141A-141A
- Desmangles JC, Buchlis JG, Shine B, Quattrin T. (2000) Is Metformin a Useful Adjunct to Insulin Therapy in Adolescents with Type 1 Diabetes in Poor Control?. Endocrine Reviews, (Aug) 444-444
- Desmangles JC, Shine B, Quattrin T. (2000) Role of Insulin-like Growth Factor-I in Monitoring GH Therapy in GH Deficient Children. Meet the Professor, (Jan) 368-368
- Provias T, Liu G, Monroe J, Wiet M, Unterman S, Quattrin T, Caron J, Carel JC, Shenker A. (2000) Incomplete Clinical Penetrance of the Activating M398T Mutation in Helix 2 of the Luteinizing Hormone Receptor (LHR). Endocrine Reviews, (Jan) 332-332
- Quattrin T, Wactawski-Wende J, Dwigun K, Liu J, Donahue RP. (1999) Is Diabetes Duration Associated with Lower Bone Mineral Density in Female Teenagers with Type I DM? Preliminary Findings. Diabetes, (Jan) A90-A90
- Quattrin T, Wactawski-Wende J, Dwigun K, Liu J, Donahue RP. (1999) Bone Mineral Density is Normal in Female Teenagers with Longstanding Type 1 Diabetes. Pediatr Res, (Jan) 96A-96A
- Grossi SG, Donahue RP, Quattrin T, Trevisan M, Ho A, Genco RJ. (1999) Periodontal Disease Increase the Risk for Insulin Resistance. J Dent Res, (Jan) 541-541
- Ciupak GL, Quattrin T, Shucard JL, Shucard DW. (1997) Further Delineation of Cognitive Abilities in Turner Syndrome: Does Estrogen Play a Role?. J Int Neuropsychol Soc, (Jan) 35-35
- Quattrin T, Thrailkill K, Baker L, Quarmby V, Compton P, Poppenheimer M, Martha PM. (1996) Low Plasma Free IGF-I Levels in IDDM: Additional Evidence for a Bi-Hormonal Defect in Diabetes. Diabetes, (May)
- Quattrin T, Feld LG, Martha PM. (1996) A Single Dose of Recombinant Human IGF-I (rhIGF-I) Does Not Affect Urinary Excretion of Nitric Oxide Metabolites in IDDM. Pediatr Res, (Jan) 96A-96A
- Campos SP, Quattrin T, Albini CH, MacGillivray MH. (1995) Response of Growth Hormone Therapy in Patients with Insulin Dependent Diabetes Mellitus and Growth Failure. Pediatr Res, (Jan) 96A-96A
- Quattrin T, Ciupak GL, Shucard DW, Shucard JL, Clopper RL, Voorhess ML. (1995) Turner Syndrome: Further Delineation of Visual Spatial Abilities and the Role of Estrogen Replacement Therapy. Pediatr Res, (Jan) 96A-96A
- Quattrin T, Campos SP, Van Liew JB, Feld LG. (1995) Urinary Excretion of Nitric Oxide Metabolites (NO2, NO3) in Subjects with IDDM and Controls. Pediatr Res, (Jan) 96A-96A
- Waz WR, Quattrin T, Feld LG. (1993) Hematuria in Children and Adolescents with Insulin Dependent Diabetes Mellitus. Pediatr Res, (Jan) 368A-368A
- Waz WR, Quattrin T, Feld LG. (1992) Serum Creatinine and Height Do Not Predict Glomerular Filtration Rate in Children with Insulin Dependent Diabetes Mellitus. Clin Res, (Jan) 663A-663A
- Quattrin T, Waz WR, Duffy LC, Feld LG. (1992) Follow-up Study of an Adolescent Population with Diabetes Screened for Microalbuminuria. Clin Res, (Jan) 658A-658A
- Waz WR, Quattrin T, Duffy LC, Cuddihy R, Feld LG. (1991) Contribution of Hypercholesterolemia to Nephropathy in Children with Insulin Dependent Diabetes Mellitus. Pediatr Res, (Jan) 200A-200A
Professional Memberships:
- Provention Bio- Consultant Tzield; Launch Meeting- Santa Monica, CA (2023–present)
- Scientific and Technical Merit Review Committee(STRC) for Stage 1 of the Integrated Canada Biomedical Research Fund and Biosciences Research Infrastructure Fund (2022–present)
- National Institute of Neurological Disorders and Stroke; Extramural Loan Repayment Program Announcement and Review for Clinical Researchers, Pediatric Research, Health Disparities Reasearch and Emerging Areas Critical to Human Health (2022–present)
- National Heart, Lung, and Blood Institute; Loan Repayment Program (2022–present)
- Highmark Western and Northern New York Inc.(previoulsy Blue Cross Blue Shield of Western New York- Health Now); Quality Improvement Committee (2021–present)
- Type 1 Diabetes TrialNet Protocol Committee "TN31-JAK Inhibition" (2021–present)
- United Way: Women‘s Leadership Council (2014–2017)
- Association for Psychological Science (2010–2017)
- Society for Clinical and Translational Science (2010–present)
- Association of Medical School Pediatric Department Chairs (2007–present)
- Erie County Medical Society (2007–present)
- American Pediatric Society (2007–present)
- Roswell Park Medical Club (2006–present)
- Medical Society of the State of New York (2005–present)
- Society for Pediatric Research (2003–present)
- American Academy of Pediatrics (1994–present)
- American Diabetes Association (1990–present)
- Pediatric Endocrine Society (1988–present)
- The Endocrine Society (1988–present)
Presentations:
- "Prescribe More Time: Potential to Delay the Onset of Stage 3 in Type 1 Diabetes with Tzield" Williamsville Pediatrics (2024)
- "Type 1 Diabetes: Screening, Staging and Management Scientific Education Program" Rochester Certified Diabetes Educators Chapter Meeting (2024)
- "Type 1 Diabetes: Staging-Treatment-Screening and Prevention" Northern Lights Health-Eastern Maine Medical Center (2024)
- "Potential to Delay Stage 3 T1D" Pediatric and Adult Endocrinologists (2024)
- "Type 1 Diabetes: A Common and Progressive Autoimmune Disease" American Society of Health Systems Pharmacists Clinical Meeting (2023)
- "Potential to Delay Stage 2 Type 1 Diabetes" Western New Chapter Nurse Practitioners (2023)
- "Potential to Delay Stage 3 Type 1 Diabetes – remote talk to Pediatric Endocrinology" University of Massachusetts Memorial Health (2023)
- "TNFa Inhibitors in Type 1 Diabetes: Current Stage of Research and Clinical Trials" Juvenile Diabetes Research Foundation Headquarters (2023)
- "Potential to Delay Stage 3 Type 1 Diabetes" Remote talk to the Endocrine Program and Diabetes Center - Massachusetts General Hospital (2023)
- "Type 1 Diabetes-A Lifelong Autoimmune Disease" New England Endocrine Alliance 15th Annual Meeting. The Revere Hotel Boston Common (2023)
- "The Future of Tyle 1 Diabetes Management. - Panelist Peer Exchange -" Sponsored by HCP Live. (2022)
- "UB CTSI Special Population Core- 2022 K Scholar Presentation. Jacobs School." (2022)
- "TNFa Inhibition for Early Intervention/Preservation of B-Cell Function in Type 1 Diabetes." American Diabetes Association Annual Meeting. (2022)
- "Preservation of Beta Cell Function in Type 1 Diabetes. National Institution of Health, Heartfield Clinical Research Center." (2022)
- "Preserving Beta cell function in T1D" Grand Rounds Division of Endocrinology NIDDK (2022)
- "Golimumab and Beta Cell Function in Youth with New Onset T1D” International Meeting on Antigen Specific Therapies for Autoimmunity with a Focus on New onset T1DM" Expert panel sponsored by Merck and Co (2021)
- "Why Blood Glucose Monitors — of All Things! — May Be the Key to Better Health in 2021" Media Interview; Parade (2021)
- "Online coloring book by UB researchers teaches kids about medical trials" Media Interview; Buffalo News (2020)
- "Changes in Transient Elastography in Obese Youth With Intensive Weight Management" Obesity Week; The Obesity Society (2018)
- "Role of Dual Contingency Management for Weight Management in Disadvantaged Families: A Pilot Study" Obesity Week; The Obesity Society (2018)
- "Enhancing Communication Using a Strength-Based Approach: Tools for Clinicians and Researchers" Pediatric Grand Rounds; University at Buffalo (2018)
- "Clinical Translational Research in Obesity and Diabetes at the University at Buffalo" (2018)
- "Blood Glucose Levels During Pregnancy on Women's Motivation to Eat" Ingestive Behavior Research Day; University at Buffalo (2018)
- "Glycemic Control and Executive Function in Adolescents with Type 1 Diabetes" 10th International Meeting of Pediatric Endocrinology; Pediatric Endocrine Society (2017)
- "New UBMD Outpatient Center at Conventus" Media Interview; WGRZ Channel 2 News (2017)
- "High Diabetes Self-Efficacy and Quality of Life Scores are Not Sufficient to Achieve Optimal Glycemic Control in Youth with Type 1 Diabetes" 77th Scientific Sessions; American Diabetes Association (2017)
- "Providers' Perceptions of Impact of EHR Changes to Promote Breastfeeding Counseling" Annual Meeting; Pediatric Academic Societies (2015)
- "Battling Obesity Starts with What You Eat" Media Interview; Time Warner Cable News (2015)
- "Careers as Physician Scientists" Medical Scientist Training Program Lecture; University at Buffalo (2015)
- "Growth Issues: Too Early? Too Late? When to Refer" 25th Annual Pediatric Symposium; Joe DiMaggio Children's Hospital (2014)
- "Metabolic Syndrome" 25th Annual Pediatric Symposium; Joe DiMaggio Children's Hospital; Round Table (2014)
- "Obesity: Guidelines for Screening/Diagnosis and Review of Successful Programs" 25th Annual Pediatric Symposium; Joe DiMaggio Children's Hospital (2014)
- "Obesity: The Challenge of Implementing the Expert Committee Recommendations in Your Busy Practice" 25th Annual Pediatric Symposium; Joe DiMaggio Children's Hospital (2014)
- "BMI Trajectory in Youth with New Onset T1DM: Can Increased Knowledge and Dietary Counseling Help?" ENDO 2013; Endocrine Society (2013)
- "Family-Based Treatment of Overweight Implemented in the Primary Care Setting" 7th Biennial Childhood Obesity Conference; California Department of Public Health (2013)
- "Enhancing Knowledge of Daycare Personnel on Healthy Weight and Nutrition Using Traditional and Web-based Approaches" Annual Meeting; Pediatric Academic Societies (2013)
- "Implementing the Expert Committee Recommendations for Early Detection, Prevention and Treatment of Overweight" 94th Annual Meeting; Central New York Pediaric Club (2013)
- "Preventing Overweight Starts Early: Buffalo Healthy Tots" International Conference on Obesity and Weight Management; OMICS Group (2012)
- "Are Children Newly Diagnosed with Type 1 Diabetes Overweight?" 72nd Scientific Sessions; American Diabetes Association (2012)
- "Parent Weight Change Predicts Child Weight Change in Family-based Weight Control Program for Pre-School Children (Buffalo Healthy Tots)" Annual Meeting; Pediatric Academic Societies (2012)
- "Parent Weight Change Predicts Child Weight Change in Family-based Weight Control Program for Pre-School Children (Buffalo Healthy Tots)" Annual Meeting; Eastern Society for Pediatric Research (2012)
- "Opening Remarks" Annual Conference; Turner Syndrome Society (2011)
- "Treating Pre-School Overweight Children in the Primary Care Setting: Preliminary Results of Buffalo Healthy Tots (BHT)" Annual Meeting; Pediatric Academic Societies/Society for Pediatric Research (2011)
- "Diabetes and Overweight: How Overweight Can Affect You and Your Family" Heart of Women‘s Health Symposium (2011)
- "Innovative Program to Prevent and Treat Overweight in Young Children" Media Interview; WGRZ Channel 2 News (2011)
- "Co-Morbidities in Overweight Children: Need for an Early Intervention" Invited Presentation; WCA Hospital (2011)
- "Inhaled Insulin: An Unfinished Story" Invited Presentation; Seattle Children‘s Hospital (2010)
- "Overweight Epidemic in Children: Early Co-Morbidities Mandate Early Intervention" Invited Presentation; Seattle Children‘s Hospital (2010)
- "Overweight Epidemic in Children" A. Conger Goodyear Installation Ceremony; University at Buffalo School of Medicine and Biomedical Sciences (2010)
- "Higher BMI and Dental Decay May Be Linked" ENDO 2010; Endocrine Society (2010)
- "Insulin and Dopamine in Overweight Youth" Pediatric Grand Rounds; University at Buffalo (2010)
- "Obesity and Mortality in Children" Media Interview; WIVB Channel 4 News (2010)
- "Screening Overweight School-aged Students at High Risk for Impaired Glucose Metabolism in the Buffalo Public Schools" 8th Joint Meeting; European Society for Pediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society; Global Care in Pediatric Endocrinology (2009)
- "Insulin and Dopamine in Overweight Youth" Naomi Berrie Diabetes Conference; Columbia University (2009)
- "Do Insulin or Dopamine Affect Energy Intake?" ENDO 2008; Endocrine Society (2008)
- "Dopamine Receptor Genotyping in Children with Short Stature Treated with Growth Hormone Therapy" ENDO 2008; Endocrine Society (2008)
- "Inhaled Insulin and Diabetes Management: Clinical Update" Pediatric Grand Rounds; University at Buffalo (2007)
- "Insulin and Diabetes Management: Clinical Update" Pediatric Grand Rounds; Golisano Children‘s Hospital (2007)
- "Insulin and Diabetes Management: Clinical Update" 6th Elizabeth R. McAnarney Lectureship; Rochester General Hospital (2007)
- "Evaluating New Options for Treating Type 2 Diabetes" Update for Pharmacists; American Health Resources (2007)
- "Growth Hormone Therapy in Children Small for Gestational Age" Invited Presentation; Saint Barnabas Medical Center (2007)
- "Type 1 and Type 2 Diabetes in Children and Adolescents: Update" Invited Presentation; St. James Mercy Health (2007)
- "Inhaled Insulin: Clinical Update" XIII Endocrinology and Metabolism Workshop; San Raffaele University (2007)
- "Growth Hormone Therapy in Children Small for Gestational Age" Invited Presentation; Suburban Pediatrics (2006)
- "Division of Endocrinology/Diabetes: Overview of the Clinical,Teaching and Research Activities" Full-Time Faculty Meeting; University at Buffalo; Department of Pediatrics (2006)
- "Inhaled Insulin: Clinical Overview" 6th Annual Diabetes Technology Meeting; Diabetes Technology Society (2006)
- "Diabetes Management at the Women and Children‘s Hospital of Buffalo: What Are We Doing Well and What Can We Do Better" Pediatric Grand Rounds; University at Buffalo (2006)
- "Medical Management of the Student with Diabetes" Buffalo District School Nurses; Women and Children‘s Hospital of Buffalo (2006)
- "Do Stimulants Affect Response to GH Therapy in GH Deficient Children?" ENDO 2006; Endocrine Society (2006)
- "MODY 5 Associated with Non-Cyctic Renal Disease and Psoriasis" ENDO 2006; Endocrine Society (2006)
- "Pediatric Obesity" Grand Rounds; Mercy Hospital of Buffalo (2006)
- "Type 2 Diabetes" Grand Rounds; Sisters of Charity Hospital (2006)
- "Treating Overweight Youth and Parents in the Pediatrician's Office: Results of a Pilot Study" Annual Meeting; Pediatric Academic Societies (2006)
- "Pediatric Obesity and Diabetes Current Practice and New Development" Kalamazoo Center for Medical Studies; Michigan State University (2005)
- "Inhaled Insulin" Media Interview; WIVB Channel 4 News (2005)
- "Inhaled Insulin Therapy: Efficacy and Safety Data" Annual Meeting; American Association of Pharmaceutical Scientists (2005)
- "Continuous Quality Improvement Issues in Pediatric Endocrinology and Diabetes" Pediatric Grand Rounds; University at Buffalo (2005)
- "Insulin Regulation: How to Be Proactive and Improve Diabetes Control" Invited Presentation; Sonoma Grille (2005)
- "Pediatric Obesity: What Can Be Done?" Childhood Obesity, Nutrition, Exercise and Smoking Symposium; American Diabetes Association/Independent Health (2005)
- "Inhaled Insulin Therapy: Current Development and Future" University Inn Conference Center; University at Buffalo (2005)
- "Management of Short Stature in Children Born Small for Gestational Age" Speaker Dinner Program; Pfizer Pharmaceuticals (2005)
- "Diminished Insulin Resistance with Weight Loss in Severely Overweight Youth" ENDO 2004; Endocrine Society (2004)
- "Follow-up Data Confirm Low BMD in Young Women with Type 1 Diabetes" 64th Scientific Sessions; American Diabetes Association (2004)
- "Insulin-like Growth Factor-I Treatment of Diabetes and Insulin Resistance" ENDO 2004; Endocrine Society (2004)
- "Insulin-like Growth Factor-I Treatment of Diabetes and Insulin Resistance" ENDO 2004; Endocrine Society (2004)
- "Increasing Obesity in Toddlers: An Emerging Public Health Problem?" Annual Meeting; Pediatric Academic Societies (2004)
- "Diabetes Mellitus in Children: Update" Invited Presentation; Western New York Chapter of Nurse Practitioners (2004)
- "Inhaled Insulin: Can it Work?" Annual Meeting; Rochester Area Diabetes Educators (2003)
- "Obesity: From Cells to Society" Community Health Network of Western New York; University at Buffalo; Office of Vice President for Research (2003)
- "New Insulin Regimes: Their Role in Intensive Insulin Management" Pediatric Grand Rounds; Children‘s Hospital of Omaha; Distinguished Lecturer (2003)
- "Development and Validation of the Parents of Children with Diabetes Questionnaire - A Questionnaire to Assess Treatment Satisfaction and Well-Being" 63rd Scientific Sessions; American Diabetes Association (2003)
- "The Obesity Epidemic" New York State Obesity Hearing; University at Buffalo; School of Public Health/School of Medicine and Biomedical Sciences (2003)
- "Early Childhood Obesity" Media Interview; MSNBC (2003)
- "Obese Children Referred to the Pediatric Endocrinologist: Characteristics and Outcome" Invited Presentation; Moscone Center (2003)
- "Juvenile Diabetes" Pediatric Grand Rounds; Sisters of Charity Hospital (2002)
- "Efficacy and Safety of Inhaled Insulin (Exubera) Compared to Conventional Subcutaneous Insulin Therapy in Patients with Type 1 Diabetes: Results of a 6-Month Randomized, Comparative Trial" 38th Annual Meeting; European Association for the Study of Diabetes (2002)
- "Obesity in Children" Media Interview; WKBW; AM Buffalo (2002)
- "Vitamin D" Media Interview; WKBW; AM Buffalo (2002)
- "Does Lower Bone Mineral Density Start in Post-Teen Years in Women with Type 1 Diabetes?" 62nd Scientific Sessions; American Diabetes Association (2002)
- "Efficacy and Safety of Inhaled Insulin (Exubera) Compared to Conventional Subcutaneous Insulin Therapy in Patients with Type 1 Diabetes: Results of a 6-Month Randomized, Comparative Trial" Intervention Expert Panel; Pfizer-Aventis (2002)
- "Diabetes Management via Continuous Subcutaneous Insulin Infusion: What to do in the School Setting" Annual Meeting; New York State School Nurses (2002)
- "Efficacy and Safety of Inhaled Insulin (Exubera) Compared to Conventional Subcutaneous Insulin Therapy in Patients with Type 1 Diabetes: Results of a 6-Month Randomized, Comparative Trial" 11th Annual Meeting and Clinical Congress; American Association of Clinical Endocrinologists (2002)
- "Type 1 Diabetes Mellitus" Media Interview; WKBW; AM Buffalo (2002)
- "Updates on the Clinical and Research Aspects of Diabetes" Support Group; Parents of Diabetics (POD) (2002)
- "IGF-I Measurement During GH Therapy: Is It Useful?" 6th Joint Meeting; European Society for Pediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society (2001)
- "Screening for Periodontal Disease in Young Patients with Type 1 Diabetes: Preliminary Findings" 61st Scientific Sessions; American Diabetes Association (2001)
- "IGF-I Measurement During GH Therapy: Is It Useful?" Annual Meeting; Society for Pediatric Research (2001)
- "IGF-I Measurement During Growth Hormone Therapy: Is It Useful?" Annual Meeting; Pediatric Academic Societies (2001)
- "Fasting Serum Glucose and Insulin and Breast Cancer Risk in Pre-Menopausal and Post Menopausal Women: The ORDET Study" Annual Meeting; American Association of Cancer Research (2001)
- "Incomplete Clinical Penetrance of the Activating M398T Mutation in Helix 2 of the Luteinizing Hormone Receptor (LHR)" 82nd Annual Meeting; Endocrine Society (2000)
- "Is Metformin a Useful Adjunct to Insulin Therapy in Adolescents with Type 1 Diabetes in Poor Control?" 82nd Annual Meeting; Endocrine Society (2000)
- "Role of Insulin-Like Growth Factor-I in Monitoring GH Therapy in GH Deficient Children" 82nd Annual Meeting; Endocrine Society (2000)
- "Potential Optimal Use and Benefit of SomatoKine in Type 1 Diabetes: What Can Be Gained" Diabetes Symposium; Celtrix (1999)
- "Is Diabetes Duration Associated with Lower Bone Mineral Density in Female Teenagers with Type I DM? Preliminary Findings" 59th Scientific Sessions; American Diabetes Association (1999)
- "Bone Mineral Density is Normal in Female Teenagers with Longstanding Type 1 Diabetes" Annual Meeting; American Pediatric Society/Society for Pediatric Research (1999)
- "Periodontal Disease Increase the Risk for Insulin Resistance" 77th General Sessions; International Association for Dental Research (1999)
- "Update on Diabetes Management and Prevention" Pediatric Grand Rounds; Sisters of Charity Hospital (1999)
- "Diabetes Mellitus - Practical Aspects for the Primary Care Physician" Pediatric Resident Conference; Women and Children's Hospital of Buffalo (1999)
- "Diabetes Screening and Prevention" Fair; St. John Parish (1999)
- "Endocrine Research Seminar" Department of Pediatrics; University at Buffalo (1999)
- "Type 1 Diabetes: Commitment to Deal with the Present and Hope for the Future" Annual Meeting; Juvenile Diabetes Foundation (JDF); Western New York Chapter (1998)
- "The Growth Hormone - Insulin-like Growth Factor-I Axis in Type 1 Diabetes: Review and New Developments" Medical Club Meeting; Roswell Park Cancer Institute (1998)
- "The Growth Hormone - Insulin-like Growth Factor-I Axis in Type 1 Diabetes: Review and New Developments" Grand Rounds; Children‘s Hospital of Birmingham/University of Alabama (1998)
- "Ambiguous Genitalia" Pediatric Resident Conference; Women and Children‘s Hospital of Buffalo (1998)
- "Diabetes Management in Children and Adolescents" Grand Rounds; Mercy Hospital (1997)
- "Advances in the Care of the Pediatric/Adolescent Patient with Diabetes Mellitus" Invited Presentation; WCA Hospital (1997)
- "Diabetes in Children and Adolescents" Diabetes Certificate Program; University at Buffalo; School of Pharmacy (1997)
- "Diabetes in the Child and Adolescent" Mini Med School; University at Buffalo; Department of Pharmacology and Toxicology (1997)
- "Insulin Dependent Diabetes Mellitus: Useful Information for the Pediatric Dentist" Medical Conditions and Considerations of the Pediatric and Adolescent Patient in Regard to Dental Treatment; Catholic Health System (1997)
- "The F0695g Study: A Phase II Randomized, Double Blind, Placebo-Controlled, Multicenter, Multidose Study of the Combined Effects of Subcutaneously Administered Insulin and rhIGF-I in Subjects with Type I Diabetes Mellitus" Experts Meeting; Roche and Genentech, Inc.; rhIGF-I in Diabetes Mellitus: Rationale and State-of-the-Art (1997)
- "Clinical Experience with Recombinant Insulin-like Growth Factor I (rhIGF-I) in Type II Diabetes Mellitus" Investigator Meeting; Genentech, Inc.; Phase III rgIGF-I Studies in Type II Diabetes Mellitus (1997)
- "Co-Therapy with Recombinant Human Insulin-like Growth Factor I Improves Glycemic Control in IDDM" 57th Scientific Sessions; American Diabetes Association (1997)
- "Effects of Co-Therapy with Recombinant Human Insulin-like Growth Factor I (rhIGF-I) and Insulin on the IGF:IGF Binding Protein (IGFBP) System in IDDM" 79th Annual Meeting; Endocrine Society (1997)
- "Recombinant Human IGF-I (rhIGF-I) Imrpoves Metabolic Control in Adolescents and Young Adults with IDDM" 5th Joint Meeting; European Society for Pediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society (1997)
- "Screening for Diabetes in Cystic Fibrosis" Lung Center Educational Conference; Women and Children‘s Hospital of Buffalo (1997)
- "Acarbose in the Treatment of Type 1 Diabetes Mellitus" Endocrinology Journal Club; University at Buffalo (1997)
- "Growth Hormone and Estrogen Therapy in Turner‘s Syndrome" Annual Family Meeting; Children‘s Growth Foundation (1997)
- "Insulin-like Growth Factor I in Insulin Dependent Diabetes Mellitus: Review and New Developments" Endocrine Grand Rounds; Case Western Reserve University (1997)
- "Further Delineation of Cognitive Abilities in Turner Syndrome: Does Estrogen Play a Role?" 25th Annual Meeting; International Neuropsychological Society (1997)
- "Insulin-like Growth Factor I in Type 1 Diabetes: Possible Therapy?" 1996 Research 2000 Lecture Series - Contemporary Diabetes Research Programs; Women and Children‘s Health Research Foundation of Women and Children‘s Hospital of Buffalo (1996)
- "Low Plasma Free IGF-I Levels in IDDM: Additional Evidence for a Bi-Hormonal Defect in Diabetes" 56th Scientific Sessions; American Diabetes Association (1996)
- "A Single Dose of Recombinant Human IFG-I (rhlGF-I) Does Not Affect Urinary Excretion of Nitric Oxide Metabolites in IDDM" Annual Meeting; American Pediatric Society/Society for Pediatric Research (1996)
- "A Randomized, Double Blind, Placebo-Controlled, Multicenter, Multidose Study of the Combined Effects of Subcutaneously Administered Insulin and rhIGF-I in Subjects with Insulin Dependent Diabetes Mellitus" Initiation Meeting of Protocol; Genentech, Inc. (1996)
- "Women with Type 1 Diabetes in the 90's" Symposium on Critical Issues in Women's Health; Mercy Health System of Western New York (1995)
- "Recombinant Human IGF-I Improves Metabolic Control in Adolescents and Young Adults with IDDM" Annual Meeting; European Association for the Study of Diabetes (1995)
- "Effects of Chronic Subcutaneous Insulin-like Growth with Factor-I (IGF-I) Administration on the IGF-I:IGFBP Aberrations in IDDM" 77th Annual Meeting; Endocrine Society (1995)
- "Insulin Dependent Diabetes: Current Trends and New Developments" Pediatric Symposium; Roswell Park Cancer Institute (1995)
- "Response of Growth Hormone Therapy in Patients with Insulin Dependent Diabetes Mellitus and Growth Failure" Annual Meeting; American Pediatric Society/Society for Pediatric Research (1995)
- "Turner Syndrome: Further Delineation of Visual Spatial Abilities and the Role of Estrogen Replacement Therapy" Annual Meeting; American Pediatric Society/Society for Pediatric Research (1995)
- "Urinary Excretion of Nitric Oxide Metabolites (NO2, NO3) in Subjects with IDDM and Controls" Annual Meeting; American Pediatric Society/Society for Pediatric Research (1995)
- "Double Blind Study of Safety, Efficacy and Metabolic Effects of Insulin-like Growth Factor I in Type 1 Diabetes" Interdisciplinary Vascular and Metabolic Research Group; Millard Fillmore Hospital (1995)
- "Phase II Double Blind Study of the Safety, Efficiency and Metabolic Effects of IGF-I in IDDM" Research Conference; Women and Children‘s Hospital of Buffalo (1995)
- "Review of the Diabetes Control Complication Trial: Implications for the Nutritionist" Western New York Chapter of Registered Dietitians; Women and Children‘s Hospital of Buffalo (1995)
- "Care Map Use and Implementation" Grand Rounds; University at Buffalo (1995)
- "Auditory Evoked Potentials and Verbal and Spatial Abilities in Preadolescent Children" Annual Meeting; Society for Neuroscience (1994)
- "Diabetes Control ComplicationsTrial: What Does It Mean?" Pediatric Grand Rounds; University at Buffalo (1994)
- "Growth Hormone, IGF-I and IGFI BP-3 in Patients with Cystic Fibrosis" 76th Annual Meeting; Endocrine Society (1994)
- "Implementing the Findings of the Diagnostic Control and Complication Trial" Annual Meeting; Society for Pediatric Research/Lawson Wilkins Pediatric Endocrine Society; Combined Scientific Session (1994)
- "Outpatient Management of Diabetic Patients" Grand Rounds; Mercy Hospital of Buffalo (1994)
- "The Management of the Surgical Patient with Insulin Dependent Diabetes Mellitus" Surgery Grand Rounds; University at Buffalo (1993)
- "High Prevalence of Low Plasma IGF-I Levels in Children and Adolescents with Insulin Dependent Diabetes Mellitus" 4th Joint Meeting; European Society for Pediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society (1993)
- "Diabetes Ketoacidosis: Clinical Aspects and Treatment" Current Issues in Pediatric Endocrinology and Diabetes: Medical and Psychoendocrine Perspectives; University at Buffalo (1993)
- "Follow-Up Study of an Adolescent Population with Diabetes Screened for Microalbuminuria" Annual Conference; Eastern Society for Pediatric Research (1992)
- "Serum Creatinine and Height Do Not Predict Glomerular Filtration Rate in Children with Insulin Dependent Diabetes Mellitus" Annual Conference; Eastern Society for Pediatric Research (1992)
- "Prospective Study of Plasma and Urinary IGF-I and IGF-II in Children with Diabetes" 74th Annual Meeting; Endocrine Society (1992)
- "Update on Insulin Dependent Diabetes and Its Complications" Pediatric Grand Rounds; University at Buffalo (1992)
- "Management of the Adolescent with Diabetes Mellitus: A Challenge for Both Patients and Physicians" Pediatric Update (1991)
- "Comparison of Enzyme Linked Immunosorbent Assay (Elisa) versus Radioimmunoassay (RIA) Methods for Quantitation of Urinary Growth Hormone (GH) Output" 73rd Annual Meeting; Endocrine Society (1991)
- "Contribution of Hypercholesterolemia to Nephropathy in Children with Insulin Dependent Diabetes Mellitus (IDDM)" Annual Meeting; Society for Pediatric Research (1991)
- "Low Urinary IGF-I and IGF-II Excretion in Children with GH Deficiency and Subjects with Idiopathic Short Stature" 73rd Annual Meeting; Endocrine Society (1991)
- "Urinary IGF-I and IGF-II Output in Newly Diagnosed IDDM Children and in Normal Controls" International Study Group of Diabetes in Children and Adolescents; American Diabetes Association (1991)
- "Insulin and Sodium Sensitivity: Preliminary Findings of a Clinical Trial" 31st Annual Conference on Cardiovascular Disease Epidemiology; American Heart Association (1991)
- "Update on IDDM Management" Pediatric Grand Rounds; Mercy Hospital of Buffalo (1991)
- "Diabetes Ketoacidosis" Grand Rounds; Sisters of Charity Hospital (1991)
- "Effects of Growth Hormone (GH) Treatment Schedule on Urinary GH and Insulin-like Growth Factor I (IGF-I) Output During Thrice Weekly vs. Daily Administration" 72nd Annual Meeting; Endocrine Society (1990)
- "Urinary Insulin-like Growth Factor II (IGF-II) and Insulin-like Growth Factor I (IGF-I) Excretion in Health Infants and Children" 72nd Annual Meeting; Endocrine Society (1990)
- "Correlation Between Serum and Urinary Growth Hormone" 71st Annual Meeting; Endocrine Society (1989)
- "Urinary Excretion of Growth Hormone (GH) and Insulin-like Growth Factor I (IGF-I) is Small for Gestational Age, Preterm and Full Term Infants and Children" 70th Annual Meeting; Endocrine Society (1988)
- "Urinary Excretion of Insulin-like Growth Factor I (IGF-I) in Pregnancy" 70th Annual Meeting; Endocrine Society (1988)
- "Quantitation of Urinary Growth Hormone (GH) and Somatomedin-C (SMC/IGF-I) in Children with Normal and Abnormal Growth" International Symposium on Growth Hormone; Serono Symposia, USA (1987)
- "Central and Peripheral Stimulation of Puberty in McCune Albright Syndrome: Multiadenomatosis?" XLIII Meeting; Italian Society of Pediatrics (1986)
- "Neonatal Transitory Diabetes Mellitus: Case Report" V Meeting; Italian Society of Pediatric Endocrinology and Diabetology (1985)
- "Prognostic Signs in the Evolution of Premature Thelarche (PT)" 2nd Joint Meeting; European Society for Pediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society (1985)
- "Growth and Maturational Responses to Thyroid Hormones" 23rd Annual Meeting; European Society for Pediatric Endocrinology (1984)
- "Variability in the Time of Disappearance of Some Manifestations of Congenital Hypothyroidism" Prime Giornate Italiane della Tiroide (1983)
- "Exogenous Infantile Obesity: A Clinical and Social Problem" IV Meeting; Italian Society of Pediatric Endocrinology and Diabetology (1983)
- "Thyroid Function in Children with Phenylketonuria (PKU)" IV Meeting; Italian Society of Pediatric Endocrinology and Diabetology (1983)
Service Activities:
- National Institute of Neurological Disorders and Stroke - Extramural Loan Repayment Program Announcement and Review for Clinical Researchers (2024)
- Spectrum News - Interview on Healthy Eating and Planning; Invited Participant (2024)
- Juvenile Diabetes Research Foundation (JDRF) - TNFa Inhibitors for T1D Workshop. JDRF Headquarters, New York, New York (2023)
- Interview with Buffalo News on Clinical Trial in Youth with Achondroplasia; Invited Participant (2023)
- International Scientific Advisory Board (ISAB) - Santobono Pediatric Hospital - Naples, Italy; Advisor (2023)
- Provention-Bio - Consultant - Tzield Launch Meeting - Santa Monica, CA; Consultant (2023)
- Department of Pediatrics Cluster Hire in Behavioral Medicine, Search Committee Member; Department of Pediatrics Cluster Hire in Behavioral Medicine, Search Committee Member (2023–present)
- Biostatistics Department Chair Search Committee; Biostatistics Department Chair Search Committee (2022–2023)
- UB School of Dental Medicine, Dean Search Committee; Dean Search Committee (2022–2023)
- UB School of Public Health and Health Professions; Biostatistics Department Chair Search Committee (2022–present)
- NIH “Post-acute Sequelae of SARS-CoV-2 Infection (PASC)” (2021–present)
- Highmark Western and Northeastern New York Inc.(previously Blue Cross Blue Shield of Western New York – Health Now) - Quality Improvement Committee; Committee Member (2021–present)
- Type 1 Diabetes TrialNet for Protocol “Anti-TNF to delay or prevent progression to stage 3 T1D” and protocol“TN31-JAK Inhibition”; TrialNet Protocols Committee Member (2021–present)
- Associated Medical Schools of New York (AMSNY) o Affiliate Membership Feasibility and Planning Committee – Jacobs School representative o Biosciences Advisory Council (2020–present)
- Faculty Mentoring Committee – Jacobs School (2019–present)
- Environmental Health Study for Western New York (EHS4WNY) - Administrative Advisory Committee (2019–present)
- Committee on Faculty and Staff Workforce Diversity (2019–present)
- Chair of the Department of Epidemiology and Environmental Health – School of Public Health and Health Professions - Search Committee (2019–present)
- CTSI Pilot Study Reviewer; reviewer (2019–present)
- NHLBI Special Emphasis Panel – UG3, U24 and R34 review (2018–2020)
- 3- day workshop in Warrenton, VA.; CTSI Mentor, Clinical Translational Scientific Award “Innovation Lab”. (2018–present)
- Stockton Kimball Award (2018–present)
- UB School of Dental Medicine- Pediatric and Community Dentistry Search (2018–present)
- CTSI Team Science Workshop – – School of Management – University at Buffalo; Presenter and Co-Leader (2018–present)
- NIH/NHLBI: Special Emphasis Panel - UG3, U24, R34; Panel Member (2017)
- Association of Medical School Pediatric Department Chairs: Annual Meeting Program Committee; Chair (2017–2018)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Ad Hoc Committee for Voluntary Faculty; Committee Member (2017)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Strategic Planning Clinical Care Committee; Committee Member (2017)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Strategic Planning Research Committee; Committee Member (2017)
- University of Liege: Marie Curie COFUND Program; Grant Reviewer (2017)
- Ad-hoc committee defining the responsibilities of voluntary faculty (2017–present)
- Jacobs School of Medicine and Biomedical Sciences Strategic Planning: Clinical Care Committee and Research committee (2017–present)
- Pediatric Academic Societies: Annual Meeting Poster Facilitator (2016)
- Association of Medical School Pediatric Department Chairs: Annual Meeting Program Committee; Chair (2016–2018)
- Kaleida Health: Medical Executive Investigation Committee; Committee Member (2016)
- Translational Research Network: Ad Hoc Committee for Conflict Resolution - Disorders/Differences of Sex Development; Committee Member (2016)
- Women and Children's Hospital of Buffalo: Child Psychiatric Special Review Committee; Committee Member (2016)
- Women and Children's Hospital of Buffalo: Physician Leadership Committee; Committee Member (2016)
- Portland State University: NIH Building University Infrastructure Leading to Diversity Initiative Program; Grant Reviewer (2016)
- Kaleida Health: Executive and Physician Leadership Relocation Team; Member (2016)
- Association of Administrators in Academic Pediatrics: AMSPDC Work Group; Member (2016)
- University at Buffalo: Center for Integrated Global Biomedical Science; Member (2016)
- Patient Centered Outcome Research Institute: Grant Reviewer Panel; Panel Member (2016)
- Pediatric Academic Societies: Annual Meeting Workshop; Reviewer (2016)
- Portland State University: NIH Building University Infrastructure Leading to Diversity Initiative Program - EXITO Pilot Projects; Reviewer (2016)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Clinical Translational Scientific Award Steering Committee; Committee Member (2016–present)
- Janssen: Type 1 Diabetes Study; Consultant (2016–present)
- University at Buffalo: Clinical Translational Scientific Institute - Integrated Special Populations; Director (2016–present)
- Association of Medical School Pediatric Department Chairs: Membership Committee; Committee Member (2015–2017)
- Association of Medical School Pediatric Department Chairs: Program Committee; Committee Member (2015–2016)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Clinical Translational Scientific Award; Grant Reviewer (2015)
- United Kingdom Ministry of Health: Diabetes Research Office; Grant Reviewer (2015)
- Blue Cross Blue Shield of Western New York: Health Now Quality Improvement Committee; Committee Member (2014–2017)
- Association of Medical School Pediatric Department Chairs; Board Member (2014–2016)
- University at Buffalo School of Dental Medicine: Decanal Review Committee; Chair (2014–2015)
- Pediatric Academic Societies: Annual Meeting Mentor/Mentee Program; Member (2014–2015)
- Society for Pediatric Research: Mentoring Committee; Committee Member (2014)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Clinical Department Performance Metrics Committee; Committee Member (2014)
- UBMD Physicians' Group: Search Committee for Executive Director; Committee Member (2014)
- Ireland Diabetes Clinical Trial Network: Health Research Board; Reviewer (2014)
- NIH Study Section: Clinical Trial Implementation Cooperative Agreement (U01) and Clinical Trial Planning Grant (R34); Reviewer (2014)
- Women and Children's Hospital of Buffalo: Fundraising Committee for Oishei Children's Hospital; Committee Member (2013–2016)
- Kaleida Health: Physician Productivity Incentive Committee; Committee Member (2013–2016)
- UBMD Physicians‘ Group: Electronic Health Records Committee; Committee Member (2013–2015)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Search Committee for Department Chair of Family Medicine; Chair (2013)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Nominee Selection Committee for American Diabetes Research Accelerator Award; Committee Member (2013)
- Empire State Clinical Investigator Program Center; Grant Reviewer (2013)
- Harvard University School of Public Health: Program for Chiefs of Clinical Services; Member (2013)
- Women and Children's Hospital of Buffalo: Strategic Council; Member (2013)
- NIH: Special Emphasis Panel/Scientific Review Group - Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery System; Panel Member (2013)
- Pediatric Academic Societies: Workshop Proposals; Reviewer (2013)
- Agency for Health Research and Quality Practice Based Research Network: Western New York Practice Innovation Network Founder and Director (2013–present)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Promotion Committee (Qualified Rank); Committee Member (2013–present)
- UBMD Physicians‘ Group: Operations Committee; Committee Member (2012–2017)
- Kaleida Health: Physician Strategy Planning Committee for Oishei Children‘s Hospital; Chair (2012–2015)
- University at Buffalo: Faculty Senate Executive Committee; Committee Member (2012)
- Pediatric Endocrinology Society: Pediatricians and Practitioners Education Committee; Committee Member (2012)
- United Way/P2 Collaborative: Early Obesity Coalition and Healthy Start Healthy Future for All Coalition; Volunteer (2012–present)
- American Diabetes Association: Scientific Sessions Abstracts; Reviewer (2011–2014)
- UBMD Physicians‘ Group: ACO Integration Committee; Committee Member (2011–2013)
- Italian Ministry of Public Education: Obesity and Endocrinology Study Sections; Reviewer (2011–2013)
- University at Buffalo: Commission of Academic Excellence and Equity; Member (2011–2012)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Decanal Review Committee; Committee Member (2011)
- National Turner Syndrome Conference: The Healthy Heart Project; Volunteer (2011)
- Greeley Company Seminar: Mastering Medical Leadership (Boca Raton, FL); Invited Participant (2010)
- Ibsen: Potential Applications of IGF-I in the Treatment of Type 2 Diabetes; Advisory Board (2010)
- Pediatric Academic Societies: Annual Meeting Workshop; Reviewer (2010)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Chairman Grand Rounds; Chair (2010–2017)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Students Interested in Pediatrics Facilitator (2010–2017)
- University at Buffalo: Clinical Forum Committee of Buffalo Niagara Medical Campus; University Representative (2010–2016)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: ACGME Committee; Committee Member (2010–2012)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Search Committee for Department Chair of Medicine; Chair (2010)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Clinical Translational Scientific Award Advisory Council; Member (2010)
- Type 1 Diabetes Exchange National Consortium: Data Collection Working Group; Member (2010)
- Versatis: Long Acting Growth Hormone Trial Advisory Panel; Panel Member (2010)
- Novo Nordisk: Pediatric Diabetes Consultant Meeting (Miami, FL); Invited Participant (2009)
- UBMD Physicians' Group; Board of Directors (2009–2010)
- University at Buffalo: Faculty Senate; Member (2009)
- Pfizer Pharmaceuticals: Pediatric Endocrinology Advisory Board Meeting (New York, NY); Invited Participant (2008)
- UBMD Physicians‘ Group: Contracting Committee; Chair (2008–2010)
- University at Buffalo Clinical and Translational Research Center: Planning Committee; Committee Member (2008–2009)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: LCME Educational Resources Committee; Committee Member (2008)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: LCME Educational Resources Finance Subcommittee; Committee Member (2008)
- University at Buffalo Clinical and Translational Research Center: Internal Advisory Council; Member (2008)
- Italian Ministry of Health: ‘Young Italian Researchers Call‘ Expert Grant Reviewer Panel; Panel Member (2008)
- UBMD Physicians‘ Group: Management Council; Member (2008–present)
- Kaleida Health: Medical Executive Committee; Committee Member (2007–2017)
- Women and Children‘s Hospital of Buffalo: Quality Leadership Council; Member (2007–2015)
- Kaleida Health: Physician Strategy Planning Committee for Oishei Children‘s Hospital; Committee Member (2007–2012)
- Seneca Diabetes Foundation Instrumental in the establishment of this endowed chair. Interest generated each year will be devoted to conduct research and provide health care professional support to the diabetic children with type 2 diabetes in the Seneca Nation and Western New York.; Chair (2007)
- Seneca Diabetes Foundation; Board of Directors (2007–present)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Faculty Council Ex-Officio Member; Chair (2007–present)
- University at Buffalo: Interdisciplinary Research Development Fund Clinical Science Panel; Panel Member (2007–present)
- Type 1 Diabetes Trial Net: Steering Committee; Committee Member (2006–2007)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Search Committee for Division Chief of General Pediatrics; Committee Member (2006)
- Independent Health: Inhaled Insulin Medical Advisory Panel; Panel Member (2006)
- American Heart Association Invited Speaker (2005)
- Seneca Diabetes Foundation; Board Member (2005–present)
- Women and Children‘s Hospital of Buffalo: Medical Advisory Committee; Committee Member (2005–2015)
- Pfizer Pharmaceuticals: 'Development of Studies on Inhaled Insulin in Pediatrics' International Advisory Board; Board Member (2005–2006)
- Insmed Incorporated: 'Planning Studies on Insulin-like Growth Factor -1/Binding Protein 3 (Iplex)' U.S. Advisory Board; Board Member (2005–2006)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Graduate Defense Committee (Jacob Barkley, PhD); Committee Member (2005–2006)
- Tercica: Development of rhInsulin-like Growth Factor 1 in Children with Short Stature; Consultant (2005–2006)
- Tercica: IFG-I Studies (Increlex) U.S. Advisory Board; Board Member (2005)
- American Diabetes Association: Annual Meeting Abstracts; Reviewer (2005–present)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences/Independent Health: Quality Improvement Projects; Participant (2004–2006)
- Children‘s Growth Foundation; Advisor (2004–present)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Graduate Defense Committee (Askia Dozier); Committee Member (2003)
- NIH: Reviewing Committee of the University of North Carolina GCRC; Committee Member (2003)
- Pfizer Pharmaceuticals: International Experts Meeting - ‘Inhaled Insulin‘ (San Francisco, CA) Invited Member and Speaker (2002)
- Novo Nordisk: Consultant Meeting (Washington, DC); Invited Participant (2002)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Ad Hoc Committee on Appointments and Promotions to Clinical Ranks; Committee Member (2002–2005)
- NIH: Site Visit for Re-accreditation of the University of North Carolina GCRC; Reviewer (2002)
- Aventis Pharmaceuticals: Consultant Meeting (Philadelphia, PA); Invited Participant (2001)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Liaison Committee on Medical Education (LCME); Committee Member (2001–2002)
- Celtrix Pharmaceuticals: National Diabetes Symposium on Phase II Trials with Somatokine (IFG-I/BP-3) in Diabetes (San Francisco, CA); Invited Participant (2000)
- Aventis Pharmaceuticals: Consultant Meeting (Buffalo, NY); Invited Participant (2000)
- Kaleida Health: Medical/Dental Staff Ad Hoc Hearing Committee; Committee Member (2000)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Faculty Council Standing Committee; Committee Member (2000–2003)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Buswell Fellowship Committee; Chair (2000–present)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Ad Hoc Billing Committee (Pediatrics); Committee Member (2000–present)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Medical Student Career Night 'Sharing Careers and Lifestyles'; Participant (1998)
- Juvenile Diabetes Foundation: Western New York Chapter - Insulin Pump Workshop; Invited Participant (1998)
- Western New York Juvenile Diabetes Foundation: Insulin Pump Workshop; Presentor (1998)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Promotions Committee (Unqualified Rank); Committee Member (1998–2000)
- University at Buffalo: Center for Integrated Outcomes Research - 'Triage of Patients with new Onset Type 1 Diabetes'; Participant (1998–2000)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Buswell Fellowship Committee; Committee Member (1998–1999)
- Brooks Memorial Hospital: Diabetes Support Group Invited Speaker (1997)
- Roche and Genentech, Inc.: International Experts Meeting - ‘rhIGF-I in Diabetes Mellitus: Rationale and State-of-the-Art‘ (London, UK); Invited Participant (1997)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Committee on Productivity In-Patient Care (Pediatrics); Committee Member (1997)
- George Washington University Biostatistics Center: 'Diabetic Retinopathy and rhIGF-I Therapy in IDDM' Consensus Expert Panel; Panel Member (1996)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Ad Hoc Committee on Promotions and Tenure (Pediatrics); Committee Member (1996–present)
- Genentech, Inc.: National Experts Planning Session (Chicago, IL); Invited Participant (1995)
- University at Buffalo: Center for the Study of Biobehavioral and Social Aspects of Health - Site Visit and Presentation For renewal of funding from SUNYAB; Participant (1995)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Faculty Council; Member (1995–1998)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Pediatric Resident Recruitment Committee; Committee Member (1995–present)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Multidisciplinary (Working) Committee on Diabetes; Committee Member (1994–1996)
- UBMD Pediatrics: Benefits Committee; Committee Member (1994–present)
- Eastern Society for Pediatric Research: Section of Endocrinology; Moderator (1993)
- University at Buffalo: Center for the Study of Biobehavioral and Social Aspects of Health - Seminar Planning Committee; Committee Member (1993–1995)
- American Diabetes Association: Patient Education Day at Medaille College (Buffalo, NY) Invited Speaker (1992)
- Gateway Youth and Family Services: Women‘s History Month; Guest Lecturer (1992)
- American Diabetes Association: Western New York Chapter; Board of Directors (1991–2000)
- Juvenile Diabetes Foundation: Western New York Chapter Annual presentation to update members regarding clinical/research activities of the Diabetes Center.; Board of Directors (1991–1993)
- American Diabetes Association: Camp Sunshine Committee (Rochester, NY); Committee Member (1991–2010)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Development of Care Maps for Diabetes Care; Participant (1990–1997)
- The Open Pediatrics Medical Journal; Editorial Board Member
- The Lancet; Reviewer
- Pediatrics (Journal of the American Academy of Pediatrics); Reviewer
- British Journal of Medicine and Medical Research; Reviewer
- Endocrine Practice; Reviewer
- Endocrinology; Reviewer
- European Journal of Clinical Investigation; Reviewer
- Expert Opinion on Drug Delivery (United Kingdom); Reviewer
- Expert Review of Endocrinology and Metabolism; Reviewer
- Growth Hormone and IGF Research; Reviewer
- Insulin; Reviewer
- International Archives of Allergy and Immunology; Reviewer
- Journal of Child Health Care; Reviewer
- Journal of Clinical Endocrinology and Metabolism; Reviewer
- Journal of Pediatrics; Reviewer
- Nature Clinical Practice Endocrinology and Metabolism; Reviewer
- Clinical Pediatrics; Reviewer
- Diabetes Care; Reviewer
- Diabetes Management; Reviewer
- Diabetes Research and Clinical Practice; Reviewer
- Diabetes Technology and Therapeutics; Reviewer
- Diabetes/Metabolism Research and Reviews; Reviewer
- Diabetologia (Journal of the European Association for the Study of Diabetes); Reviewer
- Drug Evaluations (New Zealand); Reviewer
- Drug Profiles (United Kingdom); Reviewer
- American Journal of Obstetric and Gynecology; Reviewer
- Archives of Disease in Childhood; Reviewer